EKF Diagnostics Announces Total Voting Rights and Share Capital Details

EKF Diagnostics Holdings ( (GB:EKF) ) has issued an update.

EKF Diagnostics Holdings plc has announced its total issued share capital, consisting of 454,930,564 Ordinary Shares, with 5,836,774 held in treasury, resulting in 449,093,790 shares carrying voting rights. This figure is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their investments and compliance obligations.

The most recent analyst rating on (GB:EKF) stock is a Buy with a £0.29 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Outperform.

EKF Diagnostics Holdings shows solid financial performance and robust technical indicators, both contributing to its favorable outlook. The strategic corporate actions, such as share buybacks and strong quarterly performance, further strengthen its market position. However, the relatively stable valuation limits the upside, balancing the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings plc is an AIM-listed global diagnostics company focusing on point-of-care analyzers in hematology and diabetes, as well as life sciences services that specialize in the manufacture of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling to over 120 countries worldwide.

Average Trading Volume: 589,697

Technical Sentiment Signal: Sell

Current Market Cap: £112.3M

For a thorough assessment of EKF stock, go to TipRanks’ Stock Analysis page.